Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Minimum effective volume of 0.5% bupivacaine with epinephrine in ultrasound-guided interscalene brachial plexus block

2012; Elsevier BV; Volume: 110; Issue: 3 Linguagem: Inglês

10.1093/bja/aes419

1471-6771

Luiz Fernando R. Falcão, Marcelo Vaz Perez, Isac de Castro, A. M. Yamashita, Maria Ângela Tardelli, José Luis Gomes do Amaral,

Dental Anxiety and Anesthesia Techniques

BackgroundThe use of ultrasound (US) in regional anaesthesia enables a reduction in the local anaesthetic volume. The present study aimed to determine the minimum effective volume (MEV90) of 0.5% bupivacaine with epinephrine for interscalene brachial plexus block (ISBPB).MethodsThe volume of the anaesthetic was determined using a step-up/step-down method and was based on the outcome of the preceding block. A positive or negative block resulted in a 1 ml reduction or increase in volume, respectively. The success of the block was defined as the presence of motor block in three muscle groups and the absence of thermal and pain sensations in three dermatomes within 30 min of the injection. Diaphragmatic paralysis and analgesia were assessed at 30 min, 4, and 6 h.ResultsThe MEV90 for US-guided brachial plexus block under the conditions of the present study was 0.95 ml [R2: 0.97, 95% confidence interval (CI): 0.6–1.22 ml]. The estimated maximum volume that did not cause diaphragmatic block was 4.29 ml (R2: 0.84, 95% CI: 3.56–4.98 ml). Effective postoperative analgesia was achieved with 2.34 ml (R2: 0.87, 95% CI: 0.48–11.47 ml).ConclusionsThe MEV90 of 0.5% bupivacaine with epinephrine (1:200 000) for US-guided ISBPB was 0.95 ml. Adequate postoperative analgesia and a reduced incidence of diaphragmatic block can be obtained using from 2.34 to 4.29 ml.ClinicalTrials.gov. Registry NCT01244932. The use of ultrasound (US) in regional anaesthesia enables a reduction in the local anaesthetic volume. The present study aimed to determine the minimum effective volume (MEV90) of 0.5% bupivacaine with epinephrine for interscalene brachial plexus block (ISBPB). The volume of the anaesthetic was determined using a step-up/step-down method and was based on the outcome of the preceding block. A positive or negative block resulted in a 1 ml reduction or increase in volume, respectively. The success of the block was defined as the presence of motor block in three muscle groups and the absence of thermal and pain sensations in three dermatomes within 30 min of the injection. Diaphragmatic paralysis and analgesia were assessed at 30 min, 4, and 6 h. The MEV90 for US-guided brachial plexus block under the conditions of the present study was 0.95 ml [R2: 0.97, 95% confidence interval (CI): 0.6–1.22 ml]. The estimated maximum volume that did not cause diaphragmatic block was 4.29 ml (R2: 0.84, 95% CI: 3.56–4.98 ml). Effective postoperative analgesia was achieved with 2.34 ml (R2: 0.87, 95% CI: 0.48–11.47 ml). The MEV90 of 0.5% bupivacaine with epinephrine (1:200 000) for US-guided ISBPB was 0.95 ml. Adequate postoperative analgesia and a reduced incidence of diaphragmatic block can be obtained using from 2.34 to 4.29 ml.